The FDA cleared four notable therapies within the same week in late August, spanning infectious disease, cardiometabolic care ...
In December 2025, FDA announced that it was deploying agentic AI capabilities across the agency. FDA defined these systems as ...
This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...
FDA approves Rasonque (daraxonrasib), the first broad RAS-targeted therapy for metastatic pancreatic cancer, validating RAS ...
Continuous direct compression can provide a simplified alternative pathway for selected spray-dried dispersion formulations ...
In part 2 of his overview on hold times in biopharmaceuticals, Robert Dream details the regulations that govern hold times ...
Ryan Swanson | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.
Centrix and University of Sussex launch a data analytics partnership to reduce development risk, rework and delays in early-stage pharma programs. A collaboration between Centrix Pharma Solutions, a ...
As 3D printers become more accessible and easier to use, researchers are finding new ways to incorporate this technology into their work. 1 3D bioprinters utilizing natural, synthetic, and hybrid ...
On August 19,2026, the FDA accepted Teva Pharmaceuticals' New Drug Application (NDA) for ecopipam, an investigational ...
McKesson plans to absorb Precision Medicine Group into Oncology & Multispecialty, adding CRO, lab, biomarker, market access, and commercialization capabilities to its existing healthcare services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results